UPDATE: Citi Upgrades Royalty Pharma (RPRX) to Buy
Tweet Send to a Friend
(Updated - October 29, 2021 7:05 AM EDT)
Citi analyst Andrew Baum upgraded Royalty Pharma (NASDAQ: RPRX) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Andrew Baum upgraded Royalty Pharma (NASDAQ: RPRX) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE